Joined: 5/20/2014
Posts: 4408
|
As a patient advocate and someone with early-onset Alzheimer's disease, Michael Ellenbogen presents his ideas for improving clinical trials in the US for both patients and pharma. Please see comments for summary
http://www.pharmaphorum.com/…/patient-recommendations-to-en…
|
Joined: 11/30/2011
Posts: 4460
|
That is actually from a letter that
was shared with some CEOs. In the last few months. It was even address with the
FDA. It was suggested to have it placed in one of the leading Pharma magazines
and that is how it ended up her. I have heard from others already and I do believe
it is starting to have some impact.
|
Joined: 5/20/2014
Posts: 4408
|
Great work Michael!
|
Joined: 5/20/2014
Posts: 4408
|
I search for information and there you are Michael, popping up all over the place! Your advocacy is quite extensive to say the least!
|